COM:MEIPHARMA
MEI Pharma
- Stock
Last Close
2.81
22/11 18:16
Market Cap
18.66M
Beta: -
Volume Today
6.10K
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Jun '14 | Jun '15 | Jun '16 | Jun '17 | Jun '18 | Jun '19 | Jun '20 | Jun '21 | Jun '22 | Jun '23 | Jun '24 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
average inventory | ||||||||||||
average payables | 1.12M - | 1.29M 14.52% | 971K 24.47% | 832K 14.32% | 2.11M 154.09% | 4.21M 99.39% | 3.61M 14.31% | 4.40M 21.71% | 7.14M 62.34% | 7.03M 1.55% | 4.65M 33.80% | |
average receivables | 2.64M - | 12.85M 387.18% | 14.00M 8.98% | 8.81M 37.05% | 5.06M 42.53% | 42.50K 99.16% | ||||||
book value per share | 45.05 - | 42.40 5.89% | 24.22 42.88% | 27.62 14.05% | 24.36 11.81% | 13.48 44.68% | 17.18 27.46% | 7.35 57.20% | 0.42 94.27% | 3.70 777.66% | 4.96 34.16% | |
capex per share | -0.05 - | -0.01 78.66% | -0.00 78.14% | -0.03 1,091.43% | -0.06 - | -0.20 221.78% | -0.13 35.90% | -0.00 96.94% | -0.01 36.50% | 0.00 120.01% | ||
capex to depreciation | -1 - | -0.23 76.56% | -0.07 70.57% | -0.60 770.00% | -2.71 - | -8.20 202.37% | -2.48 69.71% | -1.47 40.85% | -0.09 93.83% | 0.02 120.16% | ||
capex to operating cash flow | 0.00 - | 0.00 79.21% | 0.00 58.08% | -0.01 6,631.17% | 0.01 - | -0.03 453.84% | 0.02 184.88% | 0.01 55.64% | 0.00 93.21% | -0.00 120.80% | ||
capex to revenue | -0.00 - | -0.04 - | -0.03 29.97% | -0.03 10.33% | -0.01 57.55% | -0.00 93.91% | 0.00 114.95% | |||||
cash per share | 48.64 - | 45.23 7.02% | 26.70 40.97% | 29.10 9.01% | 49.60 70.43% | 20.94 57.78% | 40.10 91.50% | 27.27 32.00% | 1.23 95.48% | 15.11 1,127.43% | 5.76 61.90% | |
days of inventory on hand | ||||||||||||
days payables outstanding | 42.70 - | 393.05 820.39% | 409.87 4.28% | 333.02 18.75% | 1.65K 394.69% | |||||||
days sales outstanding | 391.66 - | 257.78 34.18% | 108.38 57.96% | 90.08 16.88% | 0.64 99.29% | |||||||
debt to assets | 0.05 - | 0.05 13.75% | 0.11 94.32% | |||||||||
debt to equity | 0.20 - | 0.18 8.30% | 0.52 180.98% | |||||||||
dividend yield | 0.61 - | |||||||||||
earnings yield | -0.21 - | -0.68 217.59% | -0.45 34.22% | 0.03 106.81% | -0.25 908.84% | -0.09 61.78% | -0.12 30.39% | -0.16 28.91% | -0.04 77.14% | -0.73 1,914.63% | 0.94 228.99% | |
enterprise value | 113.41M - | 29.51M 73.98% | 35.95M 21.83% | 79.53M 121.23% | 149.93M 88.53% | 169.68M 13.17% | 363.83M 114.42% | 320.46M 11.92% | 1.51B 371.97% | 39.66M 97.38% | 15.28M 61.49% | |
enterprise value over ebitda | -4.17 - | -0.90 78.38% | -1.72 90.23% | 32.21 1,976.81% | -7.96 124.72% | -2.30 71.13% | -233.07 10,036.83% | -3.66 98.43% | -15.77 330.70% | -1.04 93.38% | 0.42 139.83% | |
ev to operating cash flow | -5.83 - | -1.05 81.97% | -2.01 91.50% | 22.81 1,233.24% | -7.04 130.85% | -5.77 18.06% | 10.62 284.16% | -10.03 194.40% | -31.03 209.49% | -0.76 97.56% | -0.30 59.95% | |
ev to sales | 3.42 - | 92.43 2,602.31% | 34.52 62.65% | 12.58 63.55% | 12.55 0.27% | 37.16 196.14% | 0.81 97.81% | 0.23 71.21% | ||||
free cash flow per share | -19.44 - | -19.91 2.44% | -10.38 47.86% | 1.87 117.97% | -10.28 651.02% | -8.33 18.96% | 7.33 187.92% | -5.81 179.26% | -0.40 93.19% | -7.88 1,893.13% | -7.58 3.84% | |
free cash flow yield | -0.15 - | -0.58 279.79% | -0.38 34.44% | 0.04 110.23% | -0.13 434.25% | -0.17 26.70% | 0.09 153.65% | -0.10 214.86% | -0.03 68.18% | -1.20 3,595.47% | -2.66 122.01% | |
graham net net | 44.04 - | 41.71 5.29% | 23.49 43.68% | 26.46 12.62% | 23.43 11.43% | 12.29 47.56% | 14.59 18.71% | 4.69 67.86% | 0.28 93.94% | 0.69 141.55% | 4.50 556.28% | |
graham number | 165.64 - | 148.72 10.22% | 81.29 45.34% | 30.02 63.07% | 102.96 242.92% | 37.86 63.22% | 62.49 65.04% | 38.56 38.29% | 2.04 94.71% | 19.93 876.55% | 17.26 13.42% | |
income quality | 0.72 - | 0.86 19.83% | 0.86 0.30% | 1.31 52.53% | 0.53 59.28% | 1.75 229.05% | -0.74 142.56% | 0.63 184.89% | 0.90 41.64% | 1.65 84.15% | -2.84 272.22% | |
intangibles to total assets | 0.01 - | 0.01 29.09% | 0.01 25.30% | 0.01 23.43% | 0.00 52.40% | 0.00 11.64% | 0 100% | 0 | 0 | 0 | 0 | |
interest coverage | 0.81 - | -265.79 - | ||||||||||
interest debt per share | -16.04 - | 1.47 - | 0.08 94.59% | 1.91 2,295.47% | ||||||||
inventory turnover | ||||||||||||
invested capital | 0.20 - | 0.18 8.30% | 0.52 180.98% | 33.02M 6,388,155,776.81% | ||||||||
market cap | 127.19M - | 48.23M 62.08% | 46.78M 3.00% | 87.98M 88.06% | 163.24M 85.53% | 179.27M 9.82% | 376.16M 109.83% | 320.70M 14.74% | 1.52B 373.51% | 43.84M 97.11% | 18.98M 56.71% | |
net current asset value | 44.67M - | 59.32M 32.79% | 41.24M 30.49% | 50.46M 22.36% | 50.13M 0.65% | 47.47M 5.32% | 77.13M 62.51% | 32.08M 58.41% | 41.70M 29.98% | 11.34M 72.80% | 32.41M 185.76% | |
net debt to ebitda | 0.51 - | 0.57 12.92% | 0.52 9.61% | -3.43 762.12% | 0.71 120.63% | 0.13 81.62% | 7.90 5,978.77% | 0.00 99.96% | 0.06 2,171.30% | 0.11 73.01% | -0.10 191.72% | |
net income per share | -27.06 - | -23.18 14.34% | -12.13 47.68% | 1.45 111.96% | -19.34 1,433.41% | -4.73 75.55% | -10.10 113.69% | -8.99 11.04% | -0.44 95.11% | -4.78 986.58% | 2.67 155.87% | |
operating cash flow per share | -19.39 - | -19.90 2.64% | -10.38 47.84% | 1.89 118.24% | -10.28 642.96% | -8.27 19.56% | 7.52 190.94% | -5.68 175.52% | -0.39 93.11% | -7.88 1,911.38% | -7.58 3.79% | |
payables turnover | 8.55 - | 0.93 89.14% | 0.89 4.10% | 1.10 23.07% | 0.22 79.79% | |||||||
receivables turnover | 0.93 - | 1.42 51.93% | 3.37 137.86% | 4.05 20.31% | 574.31 14,073.84% | |||||||
research and ddevelopement to revenue | 0.31 - | 10.50 3,274.53% | 6.57 37.44% | 1.18 82.07% | 2.72 130.67% | 2.10 22.57% | 1.07 48.94% | 0.25 76.39% | ||||
return on tangible assets | -0.55 - | -0.51 7.60% | -0.45 12.26% | 0.05 110.82% | -0.38 896.24% | -0.20 46.84% | -0.22 7.50% | -0.29 32.40% | -0.31 5.95% | -0.26 14.38% | 0.43 263.06% | |
revenue per share | 12.63 - | 0.78 93.80% | 1.38 76.48% | 6.35 359.47% | 4.54 28.52% | 0.33 92.80% | 7.33 2,140.81% | 9.80 33.82% | ||||
roe | -0.60 - | -0.55 8.98% | -0.50 8.40% | 0.05 110.49% | -0.79 1,611.95% | -0.35 55.81% | -0.59 67.65% | -1.22 107.84% | -1.04 14.59% | -1.29 23.80% | 0.54 141.65% | |
roic | -0.60 - | -0.55 9.03% | -0.50 7.99% | 0.05 109.30% | -0.57 1,308.57% | -0.96 70.32% | -0.31 67.48% | -1.20 283.28% | -1.06 11.99% | -0.62 41.41% | 0.25 140.58% | |
sales general and administrative to revenue | 0.37 - | 6.03 1,525.90% | 2.97 50.78% | 0.58 80.53% | 0.96 65.36% | 0.75 21.51% | 0.68 9.56% | 0.36 47.43% | ||||
shareholders equity per share | 45.05 - | 42.40 5.89% | 24.22 42.88% | 27.62 14.05% | 24.36 11.81% | 13.48 44.68% | 17.18 27.46% | 7.35 57.20% | 0.42 94.27% | 3.70 777.66% | 4.96 34.16% | |
stock based compensation to revenue | 0.10 - | 1.98 1,901.35% | 1.34 32.68% | 0.24 82.38% | 0.40 70.57% | 0.21 48.86% | 0.07 64.17% | 0.03 52.55% | ||||
tangible asset value | 44.76M - | 59.39M 32.69% | 41.29M 30.48% | 50.51M 22.33% | 50.16M 0.68% | 47.67M 4.97% | 78.22M 64.09% | 41.36M 47.12% | 52.41M 26.72% | 24.62M 53.02% | 33.02M 34.10% | |
tangible book value per share | 44.62 - | 42.11 5.62% | 24.00 43.00% | 27.44 14.32% | 24.22 11.75% | 13.40 44.66% | 17.18 28.16% | 7.35 57.20% | 0.42 94.27% | 3.70 777.66% | 4.96 34.16% | |
working capital | 44.67M - | 59.32M 32.79% | 41.24M 30.49% | 50.46M 22.36% | 96.44M 91.14% | 67.90M 29.60% | 185.34M 172.97% | 134.52M 27.42% | 142.68M 6.07% | 87.19M 38.89% | 32.41M 62.82% |
All numbers in (except ratios and percentages)